Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 5Glioma 4Breast Neoplasms 4Prostatic Neoplasms 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Vision Disorders 1Uterine Cervical Neoplasms 1Turcot syndrome 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pituitary Neoplasms 1Peripheral Nervous System Diseases 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuritis 1Neoplasm Metastasis 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphedema 1Lung Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Familial ependymoma 1Esthesioneuroblastoma, Olfactory 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 405Radiotherapy 202Bevacizumab 157Radiation 80Magnetic Resonance Spectroscopy 77Lomustine 49Surgical Procedures, Operative 45Carmustine 41pembrolizumab 40Irinotecan 38Nivolumab 32Specimen Handling 28Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Drug Therapy 22Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15Blood Specimen Collection 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13Ipilimumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Diffusion Tensor Imaging × Clear all
NCT00662506 2023-06-06

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

National Cancer Institute (NCI)

Phase 1/2 Completed
46 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡